Guillain-Barré Syndrome Linked to COVID-19 Shots
A study by the University College London showed that serious Guillain-Barré syndrome (GBS), which can result in temporary or permanent paralysis, is a “small but significant” risk associated with AstraZeneca/Oxford University’s AZD1222 (or “Vaxzevria”) vaccine. Of the 996 cases of GBS that were recorded in the United Kingdoms’ National Immunisation Management System database between January […]
There is No Autism Epidemic?
The prevalence of autism among children in the United States in the 1960s was estimated at 1 in 10,000. By the 1980s, prevalence of the neurological condition had increased to about 2 in 10,000 children. By the 1990s, the rate under the broader classification of autism spectrum disorder (ASD) was estimated at 1 in 2,500 […]
Vaccine Injury Following Pfizer COVID-19 Shot in Australia
Faith Ranson has been in and out of hospital and suffers almost daily tics after experiencing what the latest doctor admits was an adverse reaction to the (Pfizer COVID-19] vaccine. Faith Ranson received the second dose of the Pfizer vaccine in August last year. … Three days later, I woke up one morning to go […]
The Rise of Hepatitis
The number of previously healthy children younger than 16 years of age with mysterious hepatitis cases have doubled in two weeks to 450 cases worldwide, including 11 deaths. Most cases have been reported in the U.K. (160) and the U.S. (currently, 180). In Europe most cases are found in Italy (35) and Spain (22). Over 8-14 percent […]
More Monkeypox Cases Identified as Roche is Ready With PCR Tests
There had been 584 confirmed cases of monkeypox virus in 26 countries as of May 31, 2022.1 The largest outbreak is in the United Kingdom where 190 people are infected with the virus, followed by Spain with 132 people infected, and Portugal with 100 people infected. Before this year, monkeypox in humans was thought to […]
Pfizer, Moderna Apply for EUA for COVID Shots for Infants, FDA to Decide Quickly
On June 1, 2022, Pfizer and BioNTech submitted an application to the U.S. Food and Drug Administration (FDA) for an Emergency Use Authorization (EUA) to distribute their messenger RNA (mRNA) BNT162b2 (also known as “Comirnaty”) COVID-19 biologic for children as young as six months to five years old. The application is for a three-dose regimen, […]
